Peter Wood

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

Ian W. Flinn, Richard van der Jagt, Brad S. Kahl et al. · Blood · 2014 · 623 citations · Full text

First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study

Ian W. Flinn, Richard van der Jagt, Brad S. Kahl et al. · Journal of Clinical Oncology · 2019 · 286 citations · Full text

New oral anticoagulants: a practical guide on prescription, laboratory testing and peri‐procedural/bleeding management

Huy Tran, Joanne Joseph, Laura Young et al. · Internal Medicine Journal · 2014 · 150 citations · Full text

The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma

Colm Keane, Clare Gould, Kimberley Jones et al. · Clinical Cancer Research · 2016 · 84 citations

A novel <i>in vivo</i> ovine model of transfusion‐related acute lung injury (TRALI)

John‐Paul Tung, Yoke Lin Fung, Maria Nataatmadja et al. · Vox Sanguinis · 2010 · 64 citations

Acute Lung Injury, Inflammation, Thrombosis +14